In vitro screening of understudied PFAS with a focus on lipid metabolism disruption
Archives of Toxicology · 2024
DOI: 10.1007/s00204-024-03814-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Lackson Kashobwe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vrije Universiteit Amsterdam, Amsterdam Institute for Life and Environment (A-LIFE), De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands. l.kashob…. Hauptthemen laut MEDLINE: Lipid Metabolism, Fluorocarbons. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
Per- and polyfluoroalkyl substances (PFAS) are man-made chemicals used in many industrial applications. Exposure to PFAS is associated with several health risks, including a decrease in infant birth weight, hepatoxicity, disruption of lipid metabolism, and decreased immune response. We used the in vitro cell models to screen six less studied PFAS [perfluorooctane sulfonamide (PFOSA), perfluoropentanoic acid (PFPeA), perfluoropropionic acid (PFPrA), 6:2 fluorotelomer alcohol (6:2 FTOH), 6:2 fluorotelomer sulfonic acid (6:2 FTSA), and 8:2 fluorotelomer sulfonic acid (8:2 FTSA)] for their capacity to activate nuclear receptors and to cause differential expression of genes involved in lipid metabolism. Cytotoxicity assays were run in parallel to exclude that observed differential gene expression was due to cytotoxicity. Based on the cytotoxicity assays and gene expression studies, PFOSA was shown to be more potent than other tested PFAS. PFOSA decreased the gene expression of crucial genes involved in bile acid synthesis and detoxification, cholesterol synthesis, bile acid and cholesterol transport, and lipid metabolism regulation. Except for 6:2 FTOH and 8:2 FTSA, all tested PFAS downregulated PPARA gene expression. The reporter gene assay also showed that 8:2 FTSA transactivated the farnesoid X receptor (FXR). Based on this study, PFOSA, 6:2 FTSA, and 8:2 FTSA were prioritized for further studies to confirm and understand their possible effects on hepatic lipid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vrije Universiteit Amsterdam, Amsterdam Institute for Life and Environment (A-LIFE), De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands. l.kashobwe@vu.nl.
- Department of Food Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
- Vrije Universiteit Amsterdam, Amsterdam Institute for Life and Environment (A-LIFE), De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands.
ORCID-Profile: Lackson Kashobwe
Förderung
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Kashobwe, L., Sadrabadi, F., Braeuning, A., Leonards, P. E. G., Buhrke, T., & Hamers, T. (2024). In vitro screening of understudied PFAS with a focus on lipid metabolism disruption. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03814-2
Vancouver
Kashobwe L, Sadrabadi F, Braeuning A, Leonards PEG, Buhrke T, Hamers T. In vitro screening of understudied PFAS with a focus on lipid metabolism disruption. Archives of Toxicology. 2024. doi:10.1007/s00204-024-03814-2
BibTeX
@article{Kashobwe2024,
author = {Kashobwe, Lackson and Sadrabadi, Faezeh and Braeuning, Albert and Leonards, Pim E G and Buhrke, Thorsten and Hamers, Timo},
title = {In vitro screening of understudied PFAS with a focus on lipid metabolism disruption},
journal = {Archives of Toxicology},
year = {2024},
doi = {10.1007/s00204-024-03814-2}
}
EUVIMED